Company Filing History:
Years Active: 2004-2005
Title: Vodek Sasak: Innovator in Therapeutic Materials
Introduction
Vodek Sasak is a notable inventor based in Northboro, MA (US). He has made significant contributions to the field of therapeutic materials, particularly in relation to cancer therapies and angiogenesis. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Sasak's latest patents include a method for controlling angiogenesis in animals. This method addresses disease conditions that are dependent upon or moderated by angiogenesis through the use of a therapeutic material that interacts with cell surface galectins. The therapeutic materials he has developed comprise a polymeric backbone with side chains terminating in specific sugars. Notably, these materials are based on polygalacturonic acid, with side chains that terminate in arabinose or galactose.
Another significant patent is his method for enhancing the effectiveness of cancer therapies. This innovation enhances the efficacy of conventional cancer treatments such as surgery, chemotherapy, and radiation. The therapeutic material binds to and interacts with galectins, which can enhance apoptosis and increase the effectiveness of oncolytic agents. Additionally, it can inhibit angiogenesis, thereby moderating tumor growth and metastasis.
Career Highlights
Vodek Sasak is currently associated with Glycogenesys, Inc., where he continues to develop innovative therapeutic solutions. His work is characterized by a strong focus on improving cancer treatment outcomes and understanding the mechanisms of angiogenesis.
Collaborations
Sasak collaborates with various professionals in his field, including his coworker Yan P Chang. Their combined expertise contributes to the advancement of therapeutic materials and cancer treatment methodologies.
Conclusion
Vodek Sasak's contributions to the field of therapeutic materials are significant and impactful. His innovative patents and ongoing work at Glycogenesys, Inc. highlight his commitment to improving medical treatments for cancer and related conditions.